AMBR vs ASML

AMBR's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and profitability fundamentals. The company exhibits extreme negative profit margins (-296.23%) despite a 1934.6% YoY revenue surge, signaling unsustainable growth driven by cost inefficiencies. The absence of an Altman Z-Score and a critically low quick ratio (0.18) raise serious concerns about liquidity and solvency. Although the debt/equity ratio is 0.00, the lack of operating cash flow and free cash flow data further undermines financial health. The stock trades at a premium valuation (Price/Sales: 49.46) with no earnings support, making it highly speculative.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.